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INVITED EDITORIAL ON "EFFECTS OF GLUTAMATE AND ASPARTATE ON MYOCARDIAL 
SUBSTRATE OXIDATION DURING POTASSIUM ARREST" 
Gerald D. Buckberg, MD 
T he manuscript by Reed and colleagues about the effect of glutamate and aspartate on myocardial 
substrate oxidation in isolated rat hearts was carried 
out with great biochemical expertise. The data after 
30 minutes of perfusion show complete recovery of 
function in all perfused hearts, whether beating or 
arrested, with and without uptake of glutamate and 
aspartate. In a crystalloid preparation, there was 
negligible uptake of glutamate and aspartate. They 
observed that aspartate nters the Krebs pathway 
via acetyl coenzyme A; yet the standard eviation in 
Table III of unlabeled sources is 19 _+ 18 and may 
not account for this offset directly. 
The isolated rat heart was exposed to continuous 
oxygenated crystalloid perfusion for 30 minutes. 
This lowered control oxygen consumption rate from 
53 + 10 to 22 and 17/xmol/gm dry weight. This 60% 
fall in small hearts is substantially ower than that in 
working and arrested larger dog and pig hearts, in 
which oxygen uptake is reduced 90%. More impor- 
tant, the smaller heart took up as much oxygen with 
potassium as with potassium plus glutamate cardio- 
plegia, which indicates that the 95% perfusate oxy- 
gen provided sufficient nutrition to avoid ischemia 
when glutamate and aspartate were used and func- 
tioned well in all preparations. I presumed that no 
unhealthy hearts during the stabilization period 
were discarded for reasons cited below. 
Most prior studies how that glutamate/aspartate- 
enriched cardioplegic solution improves function in 
metabolism only in injured hearts. Studies of inter- 
mittent oxygenated crystalloid solution in isolated 
rat hearts show that uptake of glucose and branch 
chain acids enhanced myocardial function, 1delayed 
postischemic contracture, raised adenosine triphos- 
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phate and creatinine phosphate l vels, reduced lac- 
tate dehydrogenase r lease after reperfusion, and 
confirmed this in phosphorus 31-nuclear magnetic 
resonance studies. 2 Specific amino acid effects could 
not be defined. The blockade of transamination by 
amino oxyacetate avoids the benefits of amino acids 
during intermittent ischemia, 3 and my colleagues 
and 14 have confirmed this after hypoxia in infant 
dog hearts with the use of a blood cardioplegic 
solution. 
Pisarenko and coworkers,  in isolated intermit- 
tently perfused rat hearts, showed that glutamate 
cardioplegia lessens ammonium accumulation, in- 
creases lactate utilization, and improves high-energy 
phosphates. Similar findings after precardioplegic 
ischemia were found by Kimose and associates, 6 
including the marked loss of glutamate in the reper- 
fusate in blood-perfused hearts (to be considered 
subsequently). We showed augmented glutamate- 
aspartate uptake after brain death in dogs 7 and in 
hypoxic infant hearts, s with no changes after blood 
cardioplegia without preceding ischemia. Rau and 
coworkers 9 observed that glutamate, aspartate, ar- 
ginine, and orthinine, all of which are associated 
with the malate-aspartate shuttle, improved posthy- 
poxic function in rabbit hearts. This may be the 
primary way to transfer equivalents across the mito- 
chondrial membrane and regulate NAD/NADH 
(nicotinamide adenine dinucleotide and nicotin- 
amide adenine dinucleotide re uced form) balance. 
Choong and Gavin 1° evaluated hypothermic St. 
Thomas' Hospital cardioplegic solution with L-as- 
partate. Storage with this solution allowed full re- 
covery of left ventricular function and reduced 
sodium and calcium uptake and high-energy phos- 
phate decline after 10 hours. The effects were 
extended to 20 hours with low perfusion pressure. 
These electrolyte ffects may be important. Lazar 
and associates 11showed that adding glutamate to 
the storage solutions provided better results than 
oxygen-derived free radical scavengers ( uperoxide 
dismutase and catalase) after 5 hours 2 storage of 
rabbit hearts. Engelman and colleagues 12studied 
regional ischemia lasting 60 minutes and showed 
that adding glutamate and aspartate to the car- 
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dioplegic solution produced better contractile func- 
tion in the ischemic segment than in controls. We 
have shown this experimentally and clinically, but 
other electrolyte cardioplegic effects, especially hy- 
pocalcemia, may have contributed to the results. 
The major finding is the relative absence of citric 
acid effects on oxygenated perfused rat hearts with 
low energy requirements. Our studies confirm this 
with intermittent blood cardioplegia with and with- 
out amino acids. There was no change in oxygen 
uptake, left ventricular compliance, or contractility 
after 3 to 4 hours of ischemia. 13-15 We also used only 
cold glutamate, and we suspect hat it acted post- 
ischemically to replace Krebs cycle intermediates 
lost during ischemia. 14 Our use is only during warm 
induction and reperfusion (5 minutes each). Rosen- 
kranz and colleagues I5 needed to study ischemia 
plus 5 minutes of reperfusion to confirm that gluta- 
mate and aspartate nrichment improved initial 
oxygen uptake, lessened anaerobic metabolism, and 
restored left ventricular function early completely. 
The major change of ischemia is defined under the 
area of study limitations, because many urgent op- 
erations are done in patients with ischemic and 
reperfusion damage. 
Pisarenko, Lepilin, and Ivanov 16 demonstrated in 
patients receiving high-dose dopamine that gluta- 
mate changed lactate production to consumption, 
reduced ammonia, showed a fivefold increase in 
glutamate uptake, and improved cardiac function by 
intravenous infusion of glutamate without changing 
oxygen demands. No control studies with volume 
infusion were made. Similar data by Thomassen and 
colleagues ~7 showed that intravenous glutamate re- 
duced ischemic threshhold by pacing by decreasing 
ST-segment depression, lowering lactate release, 
reducing fatty acid content by 20%, and raising 
myocardial glutamate uptake by 25%. Svedjeholm 
and associates, 182° following up patients who had 
coronary bypass, showed glutamate release during 
reperfusion. They demonstrated that intravenous 
glutamate with glucose-insulin-potassium increased 
myocardial oxygen uptake of glutamate and lactate 
and improved cardiac performance. The change to 
lactate production was presumed to be due to 
improvement in oxygen metabolism by glutamate. 
This group showed also evaluated the use of gluta- 
mate and glucose-insulin-potassium in patients with 
coronary disease who have depressed cardiac func- 
tion. They showed that adding these components 
after reperfusion but during bypass allows recovery 
and frequently avoids inotropic intervention by im- 
proving postoperative cardiac output metabolical- 
ly. 21 
Clearly, crystalloid cardioplegic solutions are 
more simple and economical to use than blood 
solutions. They relate to specific species. Alterna- 
tively, there are no blood components (protein, 
erythrocytes, leukocytes, platelets), and concentra- 
tions of ions like calcium and magnesium are differ- 
ent from those in blood cardioplegic solutions. They 
also must have higher oxygen tensions, which may 
be detrimental. Qui and Hearse z2 stated that blood 
perfusion should be used more frequently. For 
example, as stated in this study, insulin promotes 
uptake of amino acids by the heart and skeletal 
muscle in vitro. 23' 24 Aoki25 demonstrated that up- 
take of glutamate by insulin occurs only in the whole 
blood analyses and allowed direct passage to extra- 
cellular fluids. 
It is possible that the literature cited related to 
substrate and ischemic hearts and differences in 
cardioplegic solution used, together with the acetyl 
coenzyme A, analyses may be different from the 
experimental nd clinical effects of amino acid sup- 
plementation shown by others. The carbon 13- 
nuclear magnetic resonance spectroscopy is superb. 
It is important to repeat hese studies in an in vivo 
blood-perfused ischemic preparation before con- 
cluding that the amino acid benefits een by several 
groups are not related to augmentation f the citric 
acid cycle, predominantly after reperfusion, when 
the heart resumes aerobic work to maintain cardiac 
output. 
REFERENCES 
1. Schwalb H, Izhar U, Yaroslavsky E, Borman JB, Uretzky G. 
The effect of amino acids on the ischemic heart. J Thorac 
Cardiovasc Surg 1989;98:551-6. 
2. Schwalb H, Kushnir T, Navon G, Yaroslavsky E, Borman JB, 
Uretzky G. The protective ffect of enriched branched chain 
amino acid formulation in the ischemic heart: a phospho- 
rus-31 nuclear magnetic resonance study. J Mol Cell Cardiol 
1987;19:991-8. 
3. Bush LR, Warren S, Mesh CL, Lucchesi BR. Comparative 
effects of aspartate and glutamate during myocardial isch- 
emia. Pharmacology 1981;23:297-304. 
4. Julia P, Young HH, Buckberg GD, Kofsky ER, Bugyi HI. 
Studies of myocardial protection in the immature heart. II. 
Evidence for importance of amino acid metabolism in toler- 
ance to ischemia. J Thorac Cardiovasc Surg 1990;100:888-95. 
5. Pisarenko OI, Solomatina ES, Studneva IM, Ivanov VE, 
Kapelko VI, Smirnov VN. Protective ffect of glutamic acid 
on cardiac function and metabolism during cardioplegia and 
reperfusion. Basic Res Cardiol 1983;78:534-43. 
6. Kimose HH, Ravkilde J, Helligso P, et al. Myocardial loss of 
glutamate after cold chemical cardioplegia nd storage in 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 112, Number 6 
Buckberg 1 6 6 3 
isolated blood-perfused pig hearts. Thorac Cardiovasc Surg 
1993;41:93-100. 
7. Tixier D, Matheis G, Buckberg GD, Young HH. Donor 
hearts with impaired hemodynamics: benefit of warm sub- 
strate enriched blood cardioplegia induction during cardiac 
harvesting. J Thorac Cardiovasc Surg 1991;102:207-14. 
8. Julia P, Young HH, Buekberg GD, Kofsky ER, Bugyi HI. 
Studies of myocardial protection in the immature heart. IV. 
Improved tolerance of immature myocardium to hypoxia nd 
ischemia by intravenous metabolic support. J Thorac Cardio- 
vasc Surg 1991;101:23-32. 
9. Rau ER, Shine KI, Gervais A, Douglas AM, Amos EC. 
Enhanced mechanical recovery of anoxic and ischemic myo- 
cardium by amino acid perfusion. Am J Physiol 1979;236: 
H873-9. 
10. Choong YS, Gavin JB. L-Aspartate improves the functional 
recovery of explanted hearts sotred in St. Thomas' Hospital 
cardioplegic solution at 4 ° C. J Thorac Cardiovasc Surg 
1990;99:510-7. 
11. Lazar HL, Yang X, Rivers S, Stockwell D, Shemin RJ. 
Superiority of substrate nhancement over oxygen free rad- 
ical scavengers during extended periods of cold storage for 
cardiac transplantation. Surgery 1990;108:423-30. 
12. Engelman RM, Rousou JA, Flack JE, Iyengar J, Kimura Y, 
Das DK. Reduction of infarct size by systemic amino acid 
supplementation during reperfusion. J Thorac Cardiovasc 
Surg 1991;101:855-9. 
13. Robertson JM, Vinten-Johansen J, Buckberg GD, Follette 
DM, Maloney JV Jr. Safety of prolonged aortic clamping 
with blood cardioplegia. I. Glutamate nrichment in normal 
hearts. J Thorac Cardiovasc Surg 1984;88:395-401. 
14. Rosenkranz ER, Okamoto F, Buckberg GD. The safety of 
prolonged aortic clamping with blood cardioplegia. II. Glu- 
tamate nrichment in energy-depleted hearts. J Thorac Car- 
diovasc Surg 1984;88:401-10. 
15. Rosenkranz ER, Okamoto F, Buckberg GD, Robertson JM, 
Vinten-Johansen J, Bugyi HI. Safety of prolonged aortic 
clamping with blood cardioplegia. III. Aspartate nrichment 
of glutamate-blood cardioplegia in energy-depleted hearts 
after ischemic and reperfusion injury. J Thorac Cardiovasc 
Surg 1986;91:428-35. 
16. Pisarenko OI, Lepilin MG, Ivanov VE. Cardiac metabolism 
and performance during L-glutamic acid infusion in postop- 
erative cardiac failure. Clin Sci 1986;70:7-1212. 
17. Thomassen A, Nielsen TT, Bagger JP, Pedersen AK, Hen- 
ningsen P. Anti-ischemic and metabolic effects of glutamate 
during pacing in patients with stable angina pectoris econd- 
ary to either coronary artery disease or syndrome x. Am J 
Cardiol 1991;68:291-5. 
18. Svedjeholm R, Svensson S, Ekroth R, et al. Trauma metab- 
olism and the heart: studies of heart and leg amino acid flux 
after cardiac surgery. Thorac Cardiovasc Surg 1990;38:1-5. 
19. Svedjeholm R, Ekroth R, Joachimsson PO, Ronquist G, 
Svensson S, Tyden H. Myocardial uptake of amino acids and 
other substrates in relation to myocardial oxygen consump- 
tion four hours after cardiac operation. J Thorac Cardiovasc 
Surg 1991;101:688-94. 
20. Svedjeholm R, Vanhanen I, H~kanson E, Joachimsson PO, 
Jorfeldt L, Nilsson L. Metabolic and hemodynamic effects of 
intravenous glutamate infusion early after coronary opera- 
tions. J Thorac Cardiovasc Surg In press. 
21. Svedjeholm R, Huljebrant I, Hgkanson E, Vanhanen I. 
Glutamate and high-dose glucose-insulin-potassium (GIK) in 
the treatment of severe cardiac failure after cardiac opera- 
tions. Ann Thorac Surg 1995;59:$23-30. 
22. Qiu Y, Hearse DJ. Comparison of ischemic vulnerability and 
responsiveness to cardioplegic protection in crystalloid-per- 
fused vs. blood-perfused hearts. J Thorac Cardiovasc Surg 
1992;103:960-8. 
23. Rannels DE, Kao R, Morgan HE. Effect of insulin on 
protein turnover in heart muscle. J Biol Chem 1975;250: 
1694-701. 
24. Jefferson LS, Rannels DE, Munger BL, Morgan HE. Insulin 
in the regulation of protein turnover in heart and skeletal 
muscle. Fed Proc 1974;33:1098-104. 
25. Aoki TT, Brennan MF, Muller WA, Moore FD, Cahill GF Jr. 
Effect of insulin on muscle glutamate uptake. J Clin Invest 
1972;51:2889-94. 
